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Edited by Peter BrzezinskiAbstract To better understand the mode of action of the anti-
microbial peptide PST11-RK, we investigated its (1) bactericidal
kinetics, (2) ability to induce bacterial membrane depolarization,
(3) ability to bind to liposomes, (4) cis/trans prolyl isomerization,
(5) lipid binding kinetics and (6) translocation across lipid bilay-
ers. Our ﬁndings suggest that PST11-RK acts mainly by collaps-
ing the cytoplasmic membrane potential; it ﬁrst attaches to the
membrane via cationic C- and N-terminal residues and then in-
serts its central hydrophobic residues into the lipid interior. In
addition, it seems likely that cis/trans isomerization facilitates
the translocation of PST11-RK across the lipid bilayer, where
it may interact with secondary intracellular targets.
 2006 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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The rapidly increasing prevalence of bacterial strains resistant
to conventional antibiotics has prompted a search for new ther-
apeutic agents [1,2]. Among these are naturally occurring anti-
microbial peptides, which are known to play a crucial role in the
innate immunity of a variety ofmulticellular organisms, ranging
from insects to mammals [3–7]. Despite the considerable diver-
sity of their primary sequences, these peptides all assume a spe-
ciﬁc secondary structure – i.e., they adopt facially amphipathic
conformations in which positively charged and hydrophobic
groups segregate onto opposite faces of a-helix or b-sheet struc-
tures [8–10]. This structural feature is believed to be responsible
for their ability to kill microorganisms through disruption of
their phospholipid membranes [11–13]. Extensive eﬀorts have
been focused on the development of novel antimicrobial pep-
tides that incorporate an amphipathic a-helix or b-sheet, and
several peptides have actually proceeded into clinical trialsAbbreviations: CFU, colony forming units; KCTC, Korean Collection
of Type Cultures; diSC3(5), 3,3
0-dipropylthiacarbocyanine; SDS, sod-
ium dodecyl sulfate; NMR, nuclear magnetic resonance; POPC,
1-palmitoyl-2-oleoyl-phosphatidylcholine; POPG, 1-palmitoyl-2-oleo-
yl-phosphatidylglycerol; SUV, small unilamellar vesicle; SPR, surface
plasmon resonance
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doi:10.1016/j.febslet.2006.12.003[14,15]. On the other hand, there have been fewer studies of
other conformations such as the amphipathic turn structure.
The antimicrobial peptide tritrpticin, which is encoded within
the porcine cathelicidin cDNA, is rather small compared to
other known antimicrobial peptides; it is comprised of only 13
amino acids, while most others have 13–50 residues [16]. It has
a pseudosymmetric sequence rich in Trp and Arg residues and
forms a unique amphipathic double turn structure within which
the Trp residues are separated from the Arg residues when the
molecule is bound to sodium dodecyl sulfate (SDS) micelles
[17]. Despite its short length, tritrpticin is very eﬀective against
a wide range of pathogens, including Gram-positive and
Gram-negative bacteria and fungi [16,18]. Although the exact
mechanism by which tritrpticin kills bacteria is not fully under-
stood, it isknowntodamage target cellmembranesand to strongly
interact with and disrupt model membranes. Unfortunately, its
eﬃcient membrane-lytic activity is associated with relatively
strong cytotoxicity towards mammalian cells, such as human
erythrocytes [18,19], which would limit its therapeutic utility.
Several tritrpticin analogs have been synthesized with the aim
of improving its antimicrobial activity and reducing its toxicity
toward mammalian cells, while maintaining its short length
[20–22]. We recently designed and synthesized a novel peptide
(PST11-RK) that is perfectly symmetrical in terms of its amino
acid sequence (KKFPWWWPFKK-am) [21]. The design of
PST11-RK is based on tritrpticin’s amphipathic double-turn
conformation and, compared to the parent molecule, PST11-
RK exerts 2–8-fold greater antimicrobial activity with virtually
no hemolytic activity. We also demonstrated that the symmet-
rical peptide has antimicrobial activity against a variety of clin-
ical isolates, including methicillin-resistant Staphylococcus
aureus and vancomycin-resistant Enterococcus faecium [21].
Although its antimicrobial eﬀect is likely mediated by mem-
brane permeabilization, there is little detailed information
available about the interaction of PST11-RK with the bacterial
cell membrane. Here, we begin to characterize the interaction of
PST11-RK with lipid bilayers in order to understand how this
short peptide exerts its potent antimicrobial eﬀect. Our results
provide insight into the structural features underlying the eﬃ-
cient antibacterial activity of PST11-RK, which may be applied
to engineering antimicrobial peptides for therapeutic use.2. Materials and methods
2.1. Bacterial killing assays
Gram-positive S. aureus (KCTC 1621) and Gram-negative Esche-
richia coli (KCTC 1682) were grown to mid-log phase at 37 C in Luriablished by Elsevier B.V. All rights reserved.
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phate buﬀer (pH 7.4) and resuspended in the same buﬀer to give
approximately 2 · 106 colony forming units (CFU)/ml. PST11-RK
was then added to give an 8 lM peptide concentration and
106 CFU/ml. This mixture was incubated at 37 C, and the viabilities
of the cells were estimated at timed intervals. After 200-fold dilution
with 10 mM phosphate buﬀer, 100 ll aliquots were spread on heart
infusion agar plates and incubated for 20 h at 37 C to allow full col-
ony development. The resultant colonies were counted, and the killing
rate was determined by plotting the log CFU/ml against time. The re-
sults of three independent experiments were averaged.
2.2. Membrane depolarization assay
Cytoplasmic membrane depolarization was detected using a mem-
brane potential-sensitive probe, 3,3 0-dipropylthiacarbocyanine
(diSC3(5)). S. aureus and E. coli were grown at 37 C to mid-log phase,
centrifuged (3500 rpm, 7 min) and washed with 5 mM HEPES buﬀer
(pH 7.2) containing 20 mM glucose and resuspended in buﬀer (5 mM
HEPES buﬀer, 20 mM glucose, 100 mM KCl, pH 7.2) to an OD600
of 0.05. Changes in ﬂuorescence due to the collapse of the cytoplasmic
membrane potential were continuously monitored at 20 C using a
RF-5301 spectroﬂuorometer (Shimadzu, Tokyo, Japan) at an excita-
tion wavelength of 622 nm and an emission wavelength of 670 nm.
Once dye uptake was maximal, as indicated by a stable reduction in
ﬂuorescence due to quenching of the accumulated dye in the mem-
brane interior, PST11-RK (1–16 lM) was added to the cells. In addi-
tion, complete collapse of the membrane potential was induced using
gramicidin D (0.22 nM), which formed ion channels in the cytoplasmic
membranes of both S. aureus and E. coli, thereby dissipating the mem-
brane potential. Measurements were repeated three times under each
condition to ensure reproducibility.
2.3. Preparation of small unilamellar vesicles
Small unilamellar vesicles (SUV) were prepared by sonication for
Trp ﬂuorescence and surface plasmon resonance (SPR) experiments.
Phospholipids composed of 1-palmitoyl-2-oleoyl-phosphatidylcho-
line/1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPC/POPG) (1:1)
were dissolved in chloroform and dried with a stream of nitrogen to
form a thin lipid ﬁlm. The lipid ﬁlm was then dried under vacuum
overnight and resuspended in 20 mM sodium phosphate buﬀer via vor-
tex mixing. Using a titanium-tipped sonicator, the resultant suspension
was sonicated under nitrogen in an ice bath for about 20 min until
clear. Thereafter, dynamic light-scattering experiments conﬁrmed the
existence of a main population of vesicles (>96% mass content) with
a mean diameter of 42 nm.
2.4. Trp ﬂuorescence and quenching by acrylamide
Measurement of Trp ﬂuorescence was carried out using a Shimadzu
RF 5301 PC spectroﬂuorometer. PST11-RK (3 lM) was added to 3 ml
of Tris buﬀer (10 mM Tris, 0.1 mM EDTA, 150 mM NaCl, pH 7.4)
containing 0.6 mM liposomes. The Trp residues in the peptide were
then excited at 280 nm, and the emission spectrum was recorded from
300 to 400 nm. Acrylamide quenching experiments were carried out
using an excitation wavelength of 295 nm. Trp ﬂuorescence was
quenched by titration with acrylamide from a 4 M stock solution to
a ﬁnal concentration of 0.4 M in the presence of liposomes at a pep-
tide/lipid molar ratio of 1:100. The quenching data were analyzed in
Stern–Volmer plots using the following equation:
F 0=F ¼ 1þ KSV½Q
where F0 is the ﬂuorescence of the peptide in the absence of acrylam-
ide, F is the ﬂuorescence of the peptide in the presence of acrylamide,
KSV is the Stern–Volmer quenching constant and [Q] is the concentra-
tion of acrylamide.
2.5. NMR spectroscopy
For nuclear magnetic resonance (NMR) experiments, PST11-RK
(1 mM) was dissolved in either 9:1 H2O/D2O (pH 5.2) or 200 mM per-
deuterated SDS micelles, after which 1D 1H NMR was carried out at
25 C. NMR spectra were recorded using a Bruker DRX 600 spec-
trometer. Chemical shifts were expressed relative to the methyl reso-
nance of internal 2,2-dimethyl-2-silapentane-5-sulfonic acid at 0 ppm.
Spectra were processed and analyzed using Bruker XWIN-NMR soft-
ware.2.6. Analysis of peptide–membrane interactions using SPR
The interaction of PST11-RK with the phospholipid membrane was
analyzed by SPR using a BIACORE 2000 equipped with an L1 sensor
chip as previously described [23,24]. Brieﬂy, the running buﬀer used for
all experiments was 20 mM sodium phosphate buﬀer. The L1 sensor
chip was installed and washed with 40 mM N-octyl b-D-glucopyrano-
side (25 ll) at a ﬂow rate of 5 ll/min. Small unilamellar POPC/POPG
(2:1) vesicles were then immediately applied to the chip surface for
15 min at a ﬂow rate of 2 ll/min. To remove any multilamellar struc-
tures from the lipid surface or to regenerate the surface, 10 mM sodium
hydroxide (50 ll) was injected at ﬂow rate of 50 ll/min, which resulted
in a stable baseline. BSA was injected (25 ll, 0.1 mg/ll in sodium phos-
phate buﬀer) as a negative control; complete coverage of the chip sur-
face with lipid was conﬁrmed by the absence of nonspeciﬁc BSA
binding. Peptide solutions were then injected onto the lipid surface
for 8 min at a ﬂow rate of 5 ll/min, after which sodium phosphate buf-
fer alone was injected for 10 min to allow peptide dissociation. All
experiments were carried out at 25 C, and all solutions were freshly
prepared, degassed and ﬁltered through 0.22 lm pores. Measurements
were repeated twice under each condition to ensure reproducibility.
The sensorgrams for each peptide–lipid interaction were analyzed by
curve ﬁtting using numerical integration analysis [25]. The data were
ﬁtted globally by simultaneously ﬁtting the peptide sensorgrams
obtained at ﬁve diﬀerent concentrations using BIA evaluation software
(Version 3.2). This assay was repeated three separate times and a rep-
resentative trial is shown.
2.7. Peptide translocation
The ability of PST11-RK to translocate across a phospholipid mem-
brane was assessed using the method of Kobayashi et al. [26]. Unilamel-
lar liposomes (POPC/POPC/DNS-PE, 50:45:5) containing 200 lM
chymotrypsin in buﬀer containing 150 mM NaCl and 20 mM HEPES
(pH 7.4) were prepared by extrusion [26,27]. Trypsin-chymotrypsin
inhibitor was then added to the suspension in order to inactivate any
enzyme present outside the liposomes. A Trp-containing peptide
(PST11-RK: KKFPWWWPFKK or magainin II analog: GIGKWLH-
SAKKFGKAFVGEIMNS) was added to the suspension to a concen-
tration of 2 lM, and ﬂuorescence transfer from the Trp residues in the
peptides to the dansyl-group in DNS-PE was monitored using a Shima-
dzu RF 5301 PC spectroﬂuorometer. Excitation of Trp residues at
280 nm leads to ﬂuorescence transfer to the dansyl group in DNS-PE
and an emission recorded at 510 nm. A reduction in ﬂuorescence after
addition of peptide would indicate digestion of the internalized peptide
by the enzyme within the liposomes. Measurements were repeated three
times and a representative trial is shown.3. Results and discussion
It is noteworthy that whereas tritrpticin has both strong
antimicrobial and hemolytic activities, PST-RK is even more
eﬀective against microorganisms, but does not exhibit the cyto-
toxicity. Comprised of only 11 residues, PST11-RK is one of
the smallest antimicrobial peptides; moreover, its amino acid
composition is very simple and is without disulﬁde bonds. This
is advantageous for chemical modiﬁcation and analysis of its
structure–activity relationship, as well as for the development
of a novel class of antibiotics. Indeed, PST11-RK appears to
oﬀer a novel template for pharmaceutical compounds that
could overcome the resistance problem and could be useful
in various areas of microbiological research. Therefore our
aim in the present study was to characterize the interaction
of PST11-RK with lipid bilayers in order to understand how
this small peptide exerts its potent antimicrobial eﬀect.3.1. Bactericidal activity and membrane depolarization
Like many other antimicrobial peptides, PST11-RK folds
into an amphipathic structure that is essential to its unique
biological activities. This peptide contains three central Trp
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minal. Importantly (see below), these hydrophobic and cat-
ionic residues are separated by two Pro residues. Although
tritrpticin’s precise mechanism of action is somewhat contro-
versial, it is thought that peptide–lipid interactions leading to
membrane permeation play a key role in its activity. For that
reason, we initially studied the eﬀect of PST11-RK on the via-
bility of Gram-positive S. aureus and Gram-negative E. coli, as
well as its eﬀect on membrane potential. Fig. 1 shows the time-
dependent decline in the number of surviving cells (CFUs/ml)
with incubation in the presence of the peptide. PST11-RK
(8 lM) almost completely killed both S. aureus and E. coli
within 30 min and 60 min, respectively. When we then usedFig. 1. Kinetics of the bactericidal eﬀects of PST11-RK on S. aureus
(d) and E. coli (s). Bacteria treated with 8 lM PST11-RK were
diluted at the indicated times and then plated on LB agar. The CFUs
were then counted after 20 h of incubation at 37 C.
Fig. 2. Percent depolarization of the cytoplasmic membrane of intact
S. aureus and E. coli cells by PST11-RK. Once the ﬂuorescence had
stabilized after addition of the membrane potential-sensitive dye
DiSC3(5) to suspensions of S. aureus and E. coli cells (OD600 = 0.05),
the peptide was added. EDTA (15 mM) was used to disrupt the outer
membrane of E. coli, so that DiSC3(5) could reach the cytoplasmic
membrane. Gramicidin D (0.22 nM) was used to fully collapse of the
membrane potential.the membrane potential-sensitive dye DiSC3(5) to assess the
ability of the peptide to damage, and thus depolarize, prokary-
otic membranes, we found that addition of PST11-RK induced
concentration-dependent increases in DiSC3(5) ﬂuorescence
indicative of membrane depolarization (Fig. 2). Thus,
PST11-RK’s ability to depolarize cytoplasmic membranes
strongly suggests membrane permeabilization represents a
major killing event.
3.2. Trp ﬂuorescence and quenching of the intrinsic
ﬂuorescence by acrylamide
The most striking diﬀerence between the cytoplasmic mem-
branes of prokaryotic and eukaryotic cells is their lipid compo-
sitions. The outer membranes of bacterial cells are comprised
largely of negatively charged phospholipids like phosphatidyl-
glycerol, whereas the outer leaﬂet of the membrane of human
erythrocytes is comprised mainly of zwitterionic phospholipids
like phosphatidylcholine [28,29]. To study the interaction of
PST11-RK with membranes, we examined changes in the ﬂuo-
rescence of the Trp residues in PST11-RK in aqueous buﬀer
and in the presence of anionic POPC/POPG (1:1) liposomes
(Fig. 3A). Because the ﬂuorescence emission characteristicsFig. 3. Fluorescence emission spectrum and Stern–Volmer plots. (A)
Trp ﬂuorescence spectra of PST11-RK were obtained in the absence
(d) or presence of POPC/POPG (1:1) (s) liposomes at a molar
peptide/lipid ratio of 1:100. (B) Stern–Volmer plots for the quenching
of Trp ﬂuorescence were generated by the sequential addition of
acrylamide.
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used to monitor the binding of peptides to membranes. In
Tris–HCl buﬀer, the wavelength maximum of PST11-RK
was around 347 nm, indicating that the Trp residues were fully
exposed to the aqueous environment. By contrast, addition of
POPC/POPG (1:1) liposomes to PST11-RK resulted in a large
blue shift (10 nm) in the emission maximum and an increase in
the ﬂuorescence quantum yield, indicating that the peptide
strongly binds to the negatively charged membranes.
To further investigate the membrane-integrated state of
PST11-RK following its interaction with POPC/POPG (1:1)
liposomes, we next performed a ﬂuorescence quenching exper-
iment using the neutral quencher acrylamide. Stern–Volmer
plots for ﬂuorescence quenching of Trp by acrylamide re-
corded in the presence and absence of the liposomes are de-
picted in Fig. 3B, along with the apparent KSV values. In
buﬀer, increasing the acrylamide concentration caused eﬃcient
quenching of the ﬂuorescence of the peptide, suggesting that
Trp residues are exposed on the molecular surface of PST11-
RK facing the buﬀer. In the presence of the liposomes, how-
ever, quenching of the peptide was substantially diminished,
which is consistent with the idea that the Trp residues were
buried in the bilayer and thus less accessible to the acrylamide,
and further conﬁrms that PST11-RK’s interaction with the cell
membrane represents a primary component of its bactericidal
capacity.
3.3. Detection of proline isomerization using NMR
spectroscopy
Schibli et al. [17] used NMR spectroscopy to show that trit-
rpticin assumes multiple structural conformations in aqueous
solution due to cis/trans Pro isomerization. Indeed, because
peptidylprolyl cis/trans isomerization is slow, it can be directly
detected using NMR spectroscopy. We used the 1D 1H spec-
trum to monitor the cis/trans prolyl isomerization of PST11-
RK. The Trp indole NH signals between 9.5 and 11 ppm were
collected in 9:1 H2O/D2O (pH 5.2) or 200 mM perdeuteratedFig. 4. Trp indole NH region of the 1 H NMR spectrum of PST11-RK. The
H2O/D2O (A) or 200 mM perdeuterated SDS (B).SDS micelles (Fig. 4). In 9:1 H2O/D2O, this region would be
expected to contain three peaks due to the presence of three
Trp residues in PST11-RK, but there actually were nine peaks
in this region, which could be roughly classiﬁed into three
groups: three peaks were strong, three were intermediate and
three were weak. This indicates that in aqueous solution
PST11-RK assumes three slowly interconverting conforma-
tions produced by cis/trans isomerization of its two Pro resi-
dues. By contrast, only three major peaks were observed in
the presence of 200 mM perdeuterated SDS micelles, suggest-
ing the formation of a single stable structure.
Pro residues within membrane-active peptides have been the
focus of extensive research because they are structurally and
functionally important features in peptide–lipid interactions.
The presence of a Pro near the central region of a-helical anti-
microbial peptides contributes to partial disruption of the
structure and to selective interaction with anionic membranes
[24,27,30–32]. Pro residues within signal peptides also often
control the folding process and aﬀect the eﬃciency of translo-
cation or penetration across the membranes [33–35]. For in-
stance, most internal viral fusion peptides contain a Pro
residue thought to play a crucial role in membrane fusion
activity [36,37]. In the case of ion channel-forming peptides,
Pro residues are believed to enable formation of transmem-
brane pores or voltage-gated channels [38,39]. We suggest that
the peptidylprolyl cis/trans isomerism of PST11-RK is crucial
for its insertion into lipid membranes.
3.4. Surface plasmon resonance (SPR) analysis of
peptide-membrane binding
The antimicrobial mode of action of PST11RK is presum-
ably related to its unique composition: cationic charges (4-
Lys) direct the peptide to anionic bacterial membranes, where
hydrophobic side chains (3-Trp and 2-Phe) interact with the
core of the lipid bilayer, ultimately compromising the function
of the membrane; the two Pro residues induce conformational
changes that likely control important features of the peptide-NMR experiments were carried out at pH 5.2 and 25 C in either 9:1
Fig. 5. Sensorgrams for PST11-RK binding to POPC/POPG (1:1)
lipid bilayers immobilized on L1 sensor chip surfaces. The peptide
concentrations used were 3.125, 6.25, 12.5, 25 and 50 lM. Injections
were made at time = 0 s; phosphate buﬀer was added to initiate
dissociation at 480 s.
Fig. 6. Membrane translocation of peptides as measured by ﬂuores-
cence transfer from Trp to DNS-PE. A reduction in ﬂuorescence after
addition of a peptide (a: magainin II analog and b: PST11-RK) is
indicative of digestion of the internalized peptide by liposome-
entrapped a-chymotrypsin, which was used as a measure of membrane
translocation. The lipid concentration was 200 lM; the peptide
concentration was 2 lM.
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monitor the steps involved in the action of antimicrobial pep-
tides in real time. We used SPR to examine the binding of
PST11-RK to POPC/POPG (1:1) lipid bilayers immobilized
on a L1 sensor chip. Typical sensorgrams are shown in
Fig. 5. The dotted lines are the ﬁtted sensorgrams obtained
using a two-state model with the rate and aﬃnity constants
listed in Table 1; the solid lines are the experimental data.
The response unit intensity increased as the peptide concentra-
tion increased, indicating that the amount of peptide bound to
the lipids is proportional to the peptide concentration. When
ﬁtting the sensorgrams using diﬀerent peptide concentrations,
a two state reaction model yielded a better ﬁt than a simple
1:1 Langmuir binding model, revealing the interaction of the
peptide with lipid bilayers to be a two-step process. Kinetic
analysis of the biosensor interactions was therefore carried
out using the two-state model, which likely involves an initial
electrostatic interaction (step 1, characterized by ka1, kd1) fol-
lowed by reorientation and/or insertion of the peptide into
the hydrophobic interior (step 2, characterized by ka2, kd2).
The ability to keep both of its terminal basic residues at the
lipid–buﬀer interface, while inserting the hydrophobic central
residues into the region of the acyl chains is indicative of
PST11-RK’s considerable ﬂexibility, which is likely facilitated
by the peptidyl-prolyl cis/trans isomerization. Our present
observations are fully consistent with the proposed model
depicted in Fig. 7. Initially, both the N and C-terminal cationic
residues in aqueous solution interact with the anionic
phospholipid headgroups. In the second step, the peptide
reorients itself – i.e., the central aromatic region of the peptide
is inserted into the nonpolar interior of the lipid bilayer. Pep-Table 1
Association (ka1, ka2) and dissociation (kd1, kd2) kinetic rate constants for P
integration using a two-state reaction model
Peptide ka1 (1/Ms) kd1 (1/s)
PST11-RK 4.01 · 102 3.36 · 10-2
The aﬃnity constant (K) was determined as (ka1/kd1) (ka2/kd2).tidyl-prolyl cis/trans isomerization likely mediates the restruc-
turing of PST11-RK enabling it to translocate from aqueous
buﬀer and penetrate the target cell membranes.
3.5. Ability of PST11-RK to translocate into liposomes
Mode of action studies clearly demonstrated that the cyto-
plasmic membrane is a primary target for PST11-RK and that
membrane depolarization and disruption constitutes a signiﬁ-
cant bactericidal activity. However, although PST11-RK acted
more eﬀectively against both Gram-positive and Gram-nega-
tive bacteria, it induced less membrane depolarization in S.
aureus and less leakage from anionic liposomes than tritrpticin,
suggesting that the antimicrobial activity of this peptide may
involve mechanisms beyond simply increasing plasma mem-
brane permeability. To test that idea, we carried out transloca-
tion assays.
The translocation of PST11-RK or magainin II analog (con-
trol) across POPC/POPG (1:1) liposomes containing the ﬂuo-
rescently tagged lipid DNS-PE was studied by monitoring
degradation of the peptides by chymotrypsin entrapped within
the liposomes. To prevent peptide degradation by external
trypsin, incubations were carried out in the presence of a tryp-
sin inhibitor. Evidence for peptide translocation is shown in
Fig. 6. At time 0 s, when DNS-PE labeled vesicles (200 lM)
were added to the peptide solution (2 lM), resonance energy
transfer from central the Trp residues to DNS-PE resulted in
an initial increase in ﬂuorescence upon binding of the peptide
to the membrane. Upon translocation, the peptide should be
digested by the chymotrypsin encapsulated by the liposomes,
leading to a reduction in ﬂuorescence intensity. That weST11-RK interacting with the POPC/POPG (1:1) based on numerical
ka2 (1/s) kd2 (1/s) K(1/M)
7.19 · 10-4 10.5 · 10-4 8.17 · 103
Fig. 7. Proposed model for the interaction of PST11-RK with a target cell membrane. (A) In aqueous buﬀer, PST11-RK has no speciﬁc secondary
structure due to cis/trans isomerization of its two Pro residues. (B) The cationic properties of the N- and C-terminal residues of PST11-RK are
responsible for the initial binding to anionic membranes. (C) The structural dynamics mediated by cis/trans isomerization enable the central aromatic
residues to insert into the target cell membrane, after which PST11-RK assumes a stable amphipathic turn structure.
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over the course of the 800-s recording period indicates a com-
plete lack of membrane translocation, which is in agreement
with previously published translocation data for that peptide
[26]. By contrast, the time-dependent reduction in ﬂuorescence
seen with PST11-RK indicates the peptide eﬀectively translo-
cated across the lipid bilayer, which suggests the possibility
that PST11-RK has a secondary intracellular target.
Several studies recently showed that some peptides are very
bactericidal without inducing signiﬁcant membrane permeabi-
lization. In particular, some Pro-containing peptides eﬀectively
enter target cell membranes and interact with intracellular
macromolecules, thereby inducing cell death. For example,
Pro-rich peptides such as PR-39, Bac7, pyrrhocoricin, apidae-
cin, and drosocin are known to penetrate the cell membrane
and are thought to kill bacteria by interfering with DNA or
protein synthesis [40–42]. Similarly, indolicidin, which has
three Pro residues, can translocate across the cytoplasmic
membrane without signiﬁcant depolarization and then appears
to act against intracellular targets [43,44]. There is also evi-
dence that actions of PMAP-23 and tritrpticin, each with
two Pro residues, against intracellular targets is coupled to
membrane disruption [24,45]. Interestingly, a single Pro resi-
due promotes translocation of buforin II across lipid bilayers,
after which it strongly binds to DNA and RNA [46]. That Pro-
containing peptides are able to eﬃciently cross cell membranes
in a receptor-independent manner suggests peptidyl-prolyl cis/
trans isomerization is responsible for the import of these pep-
tides into membranes and/or the cytoplasm of cells. Our
hypothesis that the translocation of PST11-RK across lipid
bilayers is mediated by cis/trans isomerization of its two Pro
residues is consistent with that idea; however, further studies
will be needed to clarify the precise role of cis/trans isomeriza-
tion of the peptidyl prolyl bonds in translocation of peptides
across lipid bilayers.4. Conclusion
We have characterized a novel symmetric tritrpticin analog,
PST11-RK, which has potent antimicrobial activity without
hemolytic activity. The symmetric, amphipathic turn structureappears to be an attractive structural motif for potent and
selective antimicrobial activity and strong interaction with
anionic membrane components. The interaction of the peptide
with membrane surfaces involves several steps, including initial
binding (by four Lys residues) to the negatively charged sur-
face, partial or full insertion (by three Trp and two Phe resi-
dues) into the hydrophobic core of the membrane, and
ﬁnally induction of translocation (by two Pro residues) across
the lipid bilayer. In particular, peptidyl prolyl cis/trans isomer-
ization is thought to enable PST11-RK to shift between the
membrane binding and insertion steps and to enter the cyto-
plasm of the target cells. It thus appears that PST11-RK
may initiate its antimicrobial activity by permeabilizing the
cytoplasmic membranes of bacterial cells, after which it acts
against intracellular targets.
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